WAVE Life Sciences Q1 EPS $(0.24) Misses $(0.21) Estimate, Sales $12.54M Miss $22.95M Estimate
Portfolio Pulse from Benzinga Newsdesk
WAVE Life Sciences (NASDAQ:WVE) reported Q1 EPS of $(0.24), missing the $(0.21) estimate, and sales of $12.54M, missing the $22.95M estimate. This represents a 14.29% miss on EPS and a 45.37% miss on sales estimates, with a slight improvement in EPS but a decrease in sales compared to the same period last year.
May 09, 2024 | 11:34 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
WAVE Life Sciences reported lower than expected Q1 earnings and sales, missing estimates on both fronts with a slight year-over-year improvement in EPS but a decrease in sales.
Missing both EPS and sales estimates significantly, especially with a 45.37% miss on sales, is likely to negatively impact investor sentiment and stock price in the short term. The slight improvement in EPS year-over-year may not be enough to offset the negative impact of missing estimates.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100